Skip to main content
Log in

LC–MS Analysis of Sertraline and Its Active Metabolite in Human Serum Using a Silica Column with a Non-Aqueous Polar Mobile Phase

  • Full Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A sensitive liquid chromatography–mass spectrometry method for the simultaneous determination of sertraline (SER) and its major metabolite norsertraline (NOR) from serum was developed and validated in the context of a pharmacokinetic study in pregnant women. The separations were achieved on a silica column with a non-aqueous polar mobile phase consisting of acetonitrile, methanol and ammonium acetate at a flow rate of 0.5 mL min−1. The concentrations were measured using a single quadruple mass spectroscopic detector supplied with atmospheric pressure ionization electrospray. Sample preparation consisted of a simple liquid–liquid procedure. The detector was set in selective ion mode for each compound of interest, 306 m/z for SER and 275 m/z for NOR. Calibration curves were generated by least square linear regression for concentration of 5–160 ng mL−1 for SER and from 10 to 320 ng mL−1 for NOR. The curves for both compounds of interest were linear, with correlation coefficients r 2 ≥ 0.999.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Weissman MM, Leaf PJ, Holzer CE, Myers JK, Tischler GL (1984) J Affect Disord 7:179–188

    Article  CAS  Google Scholar 

  2. Marcus S, Flynn H, Blow F, Barry K (2003) J Women’s Health (Larchmt) 12:373–380

    Article  Google Scholar 

  3. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R (2008) Am J Obstet Gynecol 198:194.e1–194.e5

    Google Scholar 

  4. Eap CB, Baumann P (1996) J Chromatogr B 686:51–63

    Article  CAS  Google Scholar 

  5. Mandrioli R, Saracino MA, Ferrari S, Berardi D, Kenndler E, Raggi MA (2006) J Chromatogr B 836:116–119

    Article  CAS  Google Scholar 

  6. Freeman MP, Nolan PE Jr, Davis MF, Anthony M, Fried K, Frankhauser M, Woosley RL, Moreno F (2008) J Clin Psychopharmacol 28:646–653

    Article  CAS  Google Scholar 

  7. Rogowsky D, Marr M, Long G, Moore C (1994) J Chromatogr B 665:138–141

    Google Scholar 

  8. Kim KM, Jung BH, Choi MH, Woo JS, Paeng KJ, Chung BC (2002) J Chromatogr B 769:333–339

    Article  Google Scholar 

  9. Wille SMR, Van Hee P, Neels HM, Van Peteghem CH, Lambert WE (2007) J Chromatogr A 1176:236–245

    Article  CAS  Google Scholar 

  10. Wille SM, De Letter EA, Piette MH, Van Overschelde LK, Van Peteghem CH, Lambert WE (2009) Int J Legal Med 123:451–458

    Article  Google Scholar 

  11. Lacassie E, Gaulier J-M, Marquet P, Rabatel J-F, Lachâtre G (2000) J Chromatogr B 742:229–238

    Article  CAS  Google Scholar 

  12. Labat L, Deveaux M, Dallet P, Dubost JP (2002) J Chromatogr B 773:17–23

    Article  CAS  Google Scholar 

  13. Musenga A, Kenndler E, Mercolini L, Amore M, Fanali S, Raggi MA (2007) Electrophoresis 28:1823–1831

    Article  CAS  Google Scholar 

  14. Lucangioli SE, Hermida LG, Tripodi VP, Rodríguez VG, López EE, Rouge PD, Carducci CN (2000) J Chromatogr A 871:207–215

    Article  CAS  Google Scholar 

  15. Patel BN, Sharma N, Sanyal M, Shrivastav PS (2009) J Chromatogr B 877:221–229

    Article  CAS  Google Scholar 

  16. de Castro A, Concheiro M, Quintela O, Cruz A, López-Rivadulla M (2008) J Pharm Biomed Anal 48:183–193

    Article  Google Scholar 

  17. Frahnert C, Rao ML, Grasmäder K (2003) J Chromatogr B 794:35–47

    Article  CAS  Google Scholar 

  18. Bicker W, Wu JY, Lammerhofer M, Lindner W (2008) J Sep Sci 31:2971–2987

    Article  CAS  Google Scholar 

  19. Hao Z, Xiao B, Weng N (2008) J Sep Sci 31:1449–1464

    Article  CAS  Google Scholar 

  20. Duverneuil C, de la Grandmaison GL, de Mazancourt P, Alvarez J-C (2003) Ther Drug Monit 25:565–573

    Article  CAS  Google Scholar 

  21. Malfará WR, Bertucci C, Costa Queiroz ME, Carvalho SAD, de Bianchi M LP, Cesarino EJ, Crippa JA, Costa Queiroz RH (2007) J Pharm Biomed Anal 44:955–962

    Article  Google Scholar 

  22. Wang J-H, Lui Z-Q, Wang W, Chen X-P, Shu Y, He N, Zhou H-H (2001) Clin Pharmacol Ther 70:42–47

    Article  CAS  Google Scholar 

  23. Taylor PJ (2005) Clin Biochem 38:328–334

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Pfizer Pharmaceutical for its generosity in supplying primary standards for both SER and its metabolite NOR. We are also grateful to the staff at the University of Arizona GCRC, Tucson, AZ for drawing the timed samples and processing all the blood. In addition, we would like to thank Drs. Anne-Francoise Aubry and David K. Lloyd for their invaluable help in editing this manuscript. Foremost, we are indebted to both the FDA Office of Women’s Health and NIMH for providing the funding for this project. Finally, we thank Dr. David Bishop for proofreading the manuscript and preparing the final version of the figures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marlene P. Freeman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fried, K.M., Nolan, P.E., Anthony, M. et al. LC–MS Analysis of Sertraline and Its Active Metabolite in Human Serum Using a Silica Column with a Non-Aqueous Polar Mobile Phase. Chromatographia 73, 749–754 (2011). https://doi.org/10.1007/s10337-011-1919-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-011-1919-4

Keywords

Navigation